All manuscripts should be prepared in strict observation of the research and publication ethics guidelines recommended by the Council of Science Editors (http://www.councilscienceeditors.org/), International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/), World Association of Medical Editors (WAME, http://www.wame.org/), and the Korean Association of Medical Journal Editors (KAMJE, https://www.kamje.or.kr/en/main_en). All studies including human subjects or human data must be reviewed and approved by a responsible institutional review board (IRB).

Please refer to the principles embodied in the Declaration of Helsinki (2013; https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) for all investigations involving human materials. Animal experiments also should be reviewed by an appropriate committee for the care and use of animals. Also, studies with pathogens requiring a high degree of biosafety should pass review of a relevant committee. The approval should be described in the Methods section.

The editor of ICUrology may request submission of copies of informed consent from human subjects in clinical studies or IRB approval documents.

Authors should consult and follow the relevant guidelines for reporting health research data, such as the CONSORT guidelines (http://www.consort-statement.org/) for randomized, controlled trials and the PRISMA statement (http://www.prisma-statement.org/) for Systematic Reviews and Meta-Analyses.

A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could influence the author's decisions or work on the manuscript. Authors are required to identify all relevant financial interests and relationships or financial conflicts (e.g., employment/affiliation, grants or funding, consultancies, stock ownership or options, royalties, or patents filed, received, or pending), particularly those present at the time the research was conducted and through publication, as well as other financial interests that represent potential future financial gain. The disclosure of funding should be indicated in the Funding section within the manuscript.

The Author Submission Requirement Form should be completed by the corresponding author on behalf of each coauthor and should be submitted with the manuscript and can be found on https://www.icurology.org/src/ICU-Author_Submission_Requirement_Form.pdf.

A clinical trial defined as "any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome" should be registered to the primary registry prior to publication. ICUrology accepts registration in any of the primary registries that participate in the WHO International Clinical Trials Portal (http://www.who.int/ictrp/en/), NIH ClinicalTrials.gov (http://www.clinicaltrials.gov/), ISRCTN Register (http://www.isrctn.com/), University Hospital Medical Information Network (http://www.umin.ac.jp/ctr/index/htm/), or Clinical Research Information Service (http://cris.nih.go.kr). The clinical trial registration number shall be published at the end of the abstract.

The ICUrology requires that all authors complete an authorship form (download form at https://www.icurology.org/index.php?body=instruction) in their cover letter. The ICUrology follows the recommendations for authorship by the ICMJE, 2019 (http://www.icmje.org/icmje-recommendations.pdf). Author credit should be based on (1) substantial contributions to the conception and design, or acquisition, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged. These authorship criteria are intended to preserve the status of authorship for those who deserve credit and can take responsibility for the work.

Group authorship should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship and should complete an authorship form. The corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name.

Enter all author contributions in the submission system during submission. The contributions of all authors must be described using the CRediT Taxonomy of author roles. Read the policy.

To qualify for authorship, all contributors must meet at least one of the seven core contributions (conceptualization, methodology, software, validation, formal analysis, investigation, and data curation), as well as at least one of the writing contributions (original draft preparation, review, and editing). Authors may also satisfy the other remaining contributions; however, these alone will not qualify them for authorship.

Contributions will be published with the final article, and they should accurately reflect contributions to the work. The submitting author is responsible for completing this information at submission, and it is expected that all authors will have reviewed, discussed, and agreed to their individual contributions prior to manuscript submission.

The description of co-first authors is accepted if the corresponding author believes that such roles existed in contributing to the manuscript. For co-corresponding authors, approval from Editorial Board is required prior to submission of the manuscript.

All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgments’ section. Examples of activities that alone (without other contributions) do not qualify a contributor for authorship are acquisition of funding; general supervision of a research group or general administrative support; and writing assistance, technical editing, language editing, and proofreading.

ICUrology follow the COPE guidelines for changes in authorship. ICUrology does not correct authorship after publication, unless a mistake has been made by the Editorial Board. Any changes of authorship before publication require agreement from all authors. This includes additions, deletions, and changes in ordering. Requests must come from the corresponding author along with an explanation for the change. If the change is deemed to be appropriate, the corresponding author must receive and provide to ICUrology the consent to the change from all the authors, including any being added, deleted, or reordered.

All manuscripts from editors, employees, or members of the editorial board are processed same to other unsolicited manuscripts. During the review process, submitters will not engage in the selection of reviewers and decision process. Editors will not handle their own manuscripts although they are commissioned ones.

Ethics Committee consists of the Editor-in-Chief, Deputy Editor, Ethics Editor, members of the Ethics Committee, President of the Korean Urological Association (KUA) (https://www.urology.or.kr). The Editor-in-Chief will chair the ethics committee. The chair will convene and preside over the ethics committee.

All submitted manuscripts should be original and should not be in consideration by other scientific journals for publication. Any part of the accepted manuscript should not be duplicated in any other scientific journal without permission of the Editorial Board, although the figures and tables can be used freely if the original source is verified according to the Creative Commons Attribution License. It is mandatory for all authors to resolve any copyright issues when citing a figure or table from other journal that is not open access.

Redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s)”. Characteristics of reports that are substantially similar include the following: (a) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant publication),” (b) “the subjects or study populations are the same or overlapped,” (c) “the methodology is typically identical or nearly so,” and (d) “the results and their interpretation generally vary little, if at all.”

When submitting a manuscript, authors should include a letter informing the editor of any potential overlap with other already published material or material being evaluated for publication and should also state how the manuscript submitted to ICUrology differs substantially from other materials. If all or part of your patient population was previously reported, this should be mentioned in the Methods, with citation of the appropriate reference(s). All manuscripts are checked through a plagiarism detection program, including Similarity Check (Crosscheck) by the editorial office.

It is possible to republish manuscripts if the manuscripts satisfy the condition of secondary publication of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals by International Committee of Medical Journal Editors (ICMJE), available from http://www.icmje.org/recommendations/. These are: